Skip to content
2000
Volume 8, Issue 4
  • ISSN: 1573-4021
  • E-ISSN: 1875-6506

Abstract

Cardiovascular disease is one major cause of mortality and morbidity after renal transplantation. Management of arterial hypertension as one important risk factor is a complex problem in the ambulatory care for these patients. Offical therapeutical recommendations are vague and due to the lack of randomized controlled and prospective studies generally based on experiences in nontransplanted patient populations. New insights into different pathogenetic mechanisms have increased the awareness of transplant researchers for alternate therapeutical strategies in this patient cohort.

Loading

Article metrics loading...

/content/journals/chyr/10.2174/157340212804546062
2012-11-01
2025-12-08
Loading full text...

Full text loading...

/content/journals/chyr/10.2174/157340212804546062
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test